In this issue of Neuroimaging Clinics, guest editors Drs. Frederik Barkhof and Yaou Liu bring their considerable expertise to the topic of Multiple Sclerosis and Associated Demyelinating Disorders. Top experts in the field discuss advanced brain imaging in CNS demyelinating diseases; new imaging markers in MS and related disorders:: smoldering inflammation and central vein sign; the use of AI in MS and white matter disease; optic nerve imaging in MS and related disorders; atypical demyelinating disorders; and more.
Co-Editor Frederik Barkhof, MD, has received the National Multiple Sclerosis Society and the American Academy of Neurology’s 2018 John Dystel Prize for Multiple Sclerosis Research for his many years of outstanding research in the field of MS, especially in advancing the understanding and clinical use of brain imaging.
Diagnostic Criteria for Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Myelin Oligodendrocyte Glycoprotein-immunoglobulin G-associated Disease Routine MR Imaging Protocol and Standardization in Central Nervous System Demyelinating Diseases Advanced Brain Imaging in Central Nervous System Demyelinating Diseases New Imaging Markers in Multiple Sclerosis and Related Disorders: Smoldering Inflammation and the Central Vein Sign Network Analysis in Multiple Sclerosis and Related Disorders Spinal Cord Imaging in Multiple Sclerosis and Related Disorders Optic Nerve Imaging in Multiple Sclerosis and Related Disorders Atypical Demyelinating Disorders: MR Imaging Features, Atypical Triggers, and Etiopathogenesis Treatment Monitoring in Multiple Sclerosis - Efficacy and Safety Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging Cognitive Impairment in Multiple Sclerosis: Past, Present, and Future
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.